Charles River Laboratories | CRL - PE Price to Earnings


Charles River Laboratories reported 58.27 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Agilent 20.53 4.51 Mar/2026
Align Technology 21.8 0.98 Jun/2026
Bio-Rad Laboratories 10.01 15.27 Mar/2026
Bruker 46.54 9.74 Jun/2026
Cardinal Health 30.4 5.87 Mar/2026
Charles River Laboratories 58.27 29 Jun/2026
Cigna 11.69 0.34 Jun/2026
CVS Health 12.51 2.86 Jun/2026
Danaher 32.68 3.4 Jun/2026
Dentsply International 20.31 9.68 Mar/2026
Elevance Health 17.11 4.71 Jun/2026
Humana 24.28 13.21 Jun/2026
Illumina 48.98 16.53 Jun/2026
Incyte 14.45 0.9 Jun/2026
Intrexon 7.54 221.44 Dec/2021
IQVIA Holdings 21.45 2.08 Jun/2026
Laboratory Of America 20.47 5.04 Jun/2026
Lakefront Biotherapeutics 2.54 0.6 Mar/2026
Lonza 34.34 2.58 Dec/2025
McKesson 20.36 4.61 Jun/2026
Merck 12.74 7.82 Mar/2026
Mettler Toledo International 27.29 0.04 Jun/2026
Novartis 22.41 2.24 Jun/2026
Pfizer 11.48 2.16 Jun/2026
Quest Diagnostics 21.23 1.17 Jun/2026
Revvity 36.47 5.68 Jun/2026
Thermo Fisher Scientific 26.4 1.31 Jun/2026
United Therapeutics 19.15 1.27 Jun/2026
UnitedHealth 20.96 5.68 Jun/2026
Veradigm 11.15 4.63 Sep/2022
Waters 66.69 36.94 Jun/2026
West Pharmaceutical Services 42.63 10.64 Jun/2026